The Xenium Prime 5K assay is optimized for performance and paired with 10x Genomics' advanced multimodal cell segmentation, enabling high sensitivity, specificity and spatial fidelity.

The Xenium Prime 5K assay is optimized for performance and paired with 10x Genomics' advanced multimodal cell segmentation, enabling high sensitivity, specificity and spatial fidelity.

--10 x Genomics, Inc., a leader in single cell and spatial biology, announced today that it has shipped more than 100 Xenium Analyzer instruments in the eight months since the platform's launch.

Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. Find out why TXG is poised for sustained growth.

I. 10X Genomics Xenium (off-the-shelf panel; 1-100 add-on genes) BASIC SERVICE Fees with an off-the-shelf panel Off-the-shelf currently includes choice of 9 predesigned panels of 247-380 genes in ...

10x Genomics has no plans for launching a fourth platform in 2024—but will bring to market several new features for Xenium and a new-and-improved HD version of its Visium Spatial Gene Expression ...

Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a ...

10x sued Vizgen in 2022 for allegedly infringing patents covering its Xenium In Situ gene-analysis platform. 10x licenses the patents from Harvard, ... The case is 10x Genomics Inc v. Vizgen Inc, ...

Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a ...